Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes

International Journal of Sports Medicine

Volumn 24, Issue 5, 2003, Pages 344-351

  Hartgens, F ^a,b   Cheriex, E C ^b   Kuipers, H ^c  

^a Netherlands Ctr for Doping Affairs   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Androgenic anabolic steroids; Blood pressure; Doping; Echocardiography; Heart function; Heart morphology; Nandrolone decanoate

Indexed keywords

ANDROGEN; BOLDENONE; CHORIONIC GONADOTROPIN; CLENBUTEROL; DIANOBOL; DROSTANOLONE; DROSTANOLONE PROPIONATE; MESTEROLONE; METANDIENONE; METENOLONE; METENOLONE ACETATE; METHYLTESTOSTERONE; NANDROLONE DECANOATE; OXYMETENOLONE; OXYMETHOLONE; PLACEBO; STANOZOLOL; TAMOXIFEN; TAMOXIFEN CITRATE; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE PROPIONATE; TRENBOLONE ACETATE; UNCLASSIFIED DRUG; UNDESTOR;

ADULT; AORTA; ARTICLE; ATHLETE; BLOOD PRESSURE; BODY BUILDING; CALCULATION; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; FUNCTIONAL MORPHOLOGY; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART RIGHT VENTRICLE; HEART SIZE; HEART STROKE VOLUME; HUMAN; HUMAN EXPERIMENT; M MODE ECHOCARDIOGRAPHY; MALE; MUSCLE STRENGTH; PEAK EXPIRATORY FLOW; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; SYSTOLE;

ADULT; ANABOLIC AGENTS; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; HEART; HUMANS; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; WEIGHT LIFTING;

EID: 0041703330     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40705     Document Type: Article

References (39)

1. Appell HJ, Heller-Umpfenbach B, Feraudi M, Weicker H. Ultrastructural and morphometric investigations on the effects of training and administration of anabolic steroids on the myocardium of guinea pigs. Int J Sports Med 1983; 4: 268-274
2. Bahrke MS, Yesalis CR, Wright JE. Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update. Sports Med 1996; 22: 367-390
3. Behrendt H. Effect of anabolic steroids on rat heart muscle cells. I. Intermediate filaments. Cell Tissue Res 1977; 180: 303-315
4. Behrendt H, Boffin H. Myocardial cell lesions caused by an anabolic hormone. Cell Tissue Res 1977; 181: 423-426
5. Brown BS, Pilch AH. The effects of exercise and dianabol upon selected performances and physiological parameters in the male rat. Med Sci Sports 1972; 4: 159-165
6. de Piccoli B, Giada F, Benettin A, Sartori F, Piccolo E. Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med 1991; 12: 408-412
7. Dickerman RD, Schaller F, Zachariah NY, McConathy WJ. Left ventricular size and function in elite bodybuilders using anabolic steroids. Clin J Sport Med 1997; 7: 90-93
8. Ferenchick GS, Adelman S. Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 1992; 124: 507-508
9. nd ed: 175-224
10. Hartgens F, Kuipers H, Wijnen J, Keizer HA. Body composition, cardiovascular risk factors and liver function in long term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal. IntJ Sports Med 1996; 17: 429-433
11. Huie MJ. An acute myocardial infarction occurring in an anabolic steroid user (case study). Med Sci Sports Exerc 1994; 26: 408-413
12. Ishak KG, Zimmerman HJ. Hepatotoxic effects of the anabolic/androgenic steroids. Semin Liver Dis 1987; 7: 230-236
13. Kennedy MC, Lawrence C. Anabolic steroid abuse and cardiac death. Med J Aust 1993; 158: 346-348
14. Koert A, van Kleij R. Handel in doping. Nieuwegein: Arko Uitgeverij, 1998
15. Kutscher EC, Lund BC, Perry PJ. Anabolic steroids: a review for the clinician. Sports Med 2002; 32: 285-296
16. McKillop G, Todd IC, Ballantyne D. Increased left ventricular mass in a bodybuilder using anabolic steroids. Br J Sports Med 1986; 20: 151-152
17. Melchert RB, Welder AA. Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc 1995; 27: 1252-1262
18. Mochizucki RM, Richter KJ. Cardiomyopathy and cerebrovascular accident associated with anabolic-androgenic steroid use. Physician Sportsmed 1988; 16: 109-114
19. Moore LG, McMurtry IF, Reeves JT. Effects of sex hormones on cardiovascular and hematologic responses to chronic hypoxia in rats. Proc Soc Exp Biol Med 1978; 158: 658-662
20. Morano I, Gerstner J, Ruegg JC, Ganten U, Ganten D, Vosberg VP. Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. Circ Res 1990; 66: 1585-1590
21. Nieminen MS, Ramo MP, Viitasalo M, Heikkila P, Karjalainen J, Mantysaari M, Heikkila J. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 1996; 17: 1576-1583
22. Palatini P, Giada F, Garavelli G, Sinisi F, Mario L, Michieletto M, Baldo EG. Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 1996; 36: 1132-1140
23. Pärssinen M, Seppala T. Steroid use and long-term health risks in former athletes. Sports Med 2002; 32: 83-94
24. Pelliccia A, Maron BJ. Outer limits of the athlete's heart, the effect of gender, and relevance to the differential diagnosis with primary cardiac diseases. Cardiol Clin 1997; 15: 381-396
25. Pesola MK. Reversibility of the haemodynamic effects of anabolic steroids in rats. Eur J Appl Physiol 1988; 58: 125-131
26. Ramo P, Kettunen R, Hirvonen L. The effects of anabolic steroids and endurance training on systolic time intervals in the dog. Acta Physiol Scand 1987; 129: 543-548
27. Sachtleben TR, Berg KE, Elias BA, Cheatham JP, Felix GL, Hofschire PJ. The effects of anabolic steroids on myocardial structure and cardiovascular fitness. Med Sci Sports Exerc 1993; 25: 1240-1245
28. Salke RC, Rowland TW, Burke EJ. Left ventricular size and function in body builders using anabolic steroids. Med Sci Sports Exerc 1985; 17: 701-704
29. Spataro A, Caselli G, Pelliccia A, Biffi A, Iranquilli C, Fernando F, Marcello G. Anabolic steroids do not increase left ventricular mass index in well trained athletes (abstract). Med Sci Sports Exerc 1992; 24: S29
30. Spirito P, Pelliccia A, Proschan MA, Granata M, Spataro A, Bellone P, Caselli G, Biffi A, Vecchio C, Maron BJ. Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol 1994; 74: 802-806
31. Sullivan ML, Martinez CM, Gallagher EJ. Atrial fibrillation and anabolic steroids. J Emerg Med 1999; 17: 851-857
32. Tagarakis CV, Bloch W, Hartmann G, Hollmann W, Addicks K. Anabolic steroids impair the exercise-induced growth of the cardiac capillary bed. Int J Sports Med 2000; 21: 412-418
33. Tagarakis CV, Bloch W, Hartmann G, Hollmann W, Addicks K. Testosterone-propionate impairs the response of the cardiac capillary bed to exercise. Med Sci Sports Exerc 2000; 32: 946-953
34. Thomas LR, Douglas PS. Echocardiographic findings in athletes. In: Thompson PD (ed). Exercise and Sports Cardiology. New York: McGraw-Hill, 2001: 43-70
35. Thompson PD, Sadaniantz A, Cullinane EM, Bodziony KS, Catlin DH, Torek BG, Douglas PS. Left Ventricular function is not impaired in weight-lifters who use anabolic steroids. J Am Coll Cardiol 1992; 19: 278-282
36. Urhausen A, Holpes R, Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol 1989; 58: 633-640
37. Yeater R, Reed C, Ullrich I, Morise A, Borsch M. Resistance trained athletes using or not using anabolic steroids compared to runners: Effects on cardiorespiratory variables, body composition, and plasma lipids. Br J Sports Med 1996; 30: 11-14
38. Yesalis C. Anabolic steroids in sport and exercise. Champaign, IL: Human Kinetics, 2000; 2nd ed
39. Zuliani U, Bernardini B, Catapano A, Campana M, Cerioli G, Spattini M. Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body builders. Int J Sports Med 1989; 10: 62-66